Alto Neuroscience Inc. (ANRO)
Alto Neuroscience Statistics
Share Statistics
Alto Neuroscience has 27.07M shares outstanding. The number of shares has increased by 0.7% in one year.
| 27.07M |
| 0.7% |
| 0.38% |
| 82.31% |
| 21.49M |
| 1,971 |
| 0.76% |
Short Selling Information
The latest short interest is 3.01M, so 11.11% of the outstanding shares have been sold short.
| 3.01M |
| 11.11% |
| 14.11% |
| 16.38 |
Valuation Ratios
The PE ratio is -1.69 and the forward PE ratio is -0.86. Alto Neuroscience's PEG ratio is -0.02.
| -1.69 |
| -0.86 |
| 0 |
| 1.5 |
| 0.69 |
| -2.1 |
| -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Alto Neuroscience.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 16.92, with a Debt / Equity ratio of 0.11.
| 16.92 |
| 16.92 |
| 0.11 |
| -0.25 |
| -0.34 |
| 49.9 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-808,302.63 |
| 76 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -78.24% in the last 52 weeks. The beta is 1.93, so Alto Neuroscience's price volatility has been higher than the market average.
| 1.93 |
| -78.24% |
| 2.37 |
| 5.45 |
| 50.68 |
| 259,811 |
Balance Sheet
The company has 168.23M in cash and 16.94M in debt, giving a net cash position of 151.28M.
| 168.23M |
| 16.94M |
| 151.28M |
| -138.4M |
| 171.91M |
| 156.27M |
Cash Flow
In the last 12 months, operating cash flow was -47.42M and capital expenditures -2.08M, giving a free cash flow of -49.5M.
| -47.42M |
| -2.08M |
| -49.5M |
| -2.01 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
ANRO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for ANRO is $10, which is 289.1% higher than the current price. The consensus rating is "Buy".
| $10 |
| 289.1% |
| Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -0.02 |
| 2 |